Emma Heming Willis is sharing new details about husband Bruce Willis' frontotemporal dementia diagnosis. During Wednesday's episode of the "Conversations with Cam" podcast, the 47-year-old opened up ...
HOUSTON, January 05, 2026--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance ...
A new Northwestern University study using patient nervous tissue and lab-grown human neurons has uncovered how a key disease protein, TDP-43, drives overactive nerve cells in the neurodegenerative ...
Emma Heming Willis has had to adapt to life as not only a wife but as a caregiver of her husband, Bruce Willis, as he battles frontotemporal dementia (FTD). And one of those shifts is in the way they ...
The second Emma Heming Willis popped up on the Zoom screen, a wave of grief washed over me. A sudden sensation all too familiar. I'm not always this candid with my interview subjects. But when topics ...
Corinne Purtill is a science and medicine reporter for the Los Angeles Times. Her writing on science and human behavior has appeared in the New Yorker, the New York Times, Time Magazine, the BBC and ...
How can apathy be managed in an individual with frontotemporal dementia? Frontotemporal dementia or frontotemporal degeneration (FTD) refers to a range of disorders that impact the brain’s frontal ...
- AVB-101 is an investigational one-time therapy designed to deliver a functional copy of the GRN gene directly to the brain, thereby potentially restoring progranulin levels and stopping disease ...
Dementia usually affects older people, so when it occurs in middle age, it can be hard to recognize. The most common form is frontotemporal dementia (FTD), which is often mistaken for depression, ...
(RTTNews) - NKGen Biotech (NKGN), Friday revealed the administration of the first dose of its autologous NK cell therapy, troculeucel, to a frontotemporal dementia or FTD patient under an FDA-cleared ...
Coya Therapeutics, Inc. has Treg therapies for neurodegenerative and autoimmune diseases, targeting ALS, FTD, AD, and PD. However, their lead candidate is now clearly COYA 302. This drug basically ...
Antonia Haynes is a Game Rant writer who resides in a small seaside town in England where she has lived her whole life. Beginning her video game writing career in 2014, and having an avid love of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results